The Daily Impact: India Develops Promising Rotavirus Vaccine

The following two tabs change content below.

May 16, 2013 Phase III trials of the Rotavac Rotavirus Vaccine show that it has the potential to save thousands of lives, say scientists. From the BBC: Rotavirus causes dehydration and severe diarrhoea and spreads through contaminated hands and surfaces and is rampant in Asia and Africa. India says clinical trials show the new vaccine, Rotavac, can save the lives of thousands of children annually. An Indian manufacturer said the vaccine would cost 54 rupees ($1; £0.65). International pharmaceutical companies GlaxoSmithKline and Merck produce similar vaccines but each dose costs around 1,000 rupees. “This is an important scientific breakthrough against rotavirus infections, the most severe and lethal cause of childhood diarrhoea, responsible for approximately 100,000 deaths of small children in India each year,” India’s Department of Biotechnology official K Vijay Raghavan said

Go here to read the rest:
The Daily Impact: India Develops Promising Rotavirus Vaccine